Alpha Healthcare Acquisit... (ALPAU)
NASDAQ: ALPAU
· Real-Time Price · USD
9.75
0.31 (3.28%)
At close: Jul 14, 2023, 4:09 PM
Alpha Healthcare Acquisition III Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Revenue | 510.35K | -3.73M | 20.52K | 12.32K | 3.73M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 240.53K | 1.54M | 4.84K | 292.00 | 1.54M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 269.82K | -2.18M | 15.68K | 12.03K | 2.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -1.51M | 5.4M | -1.42M | -1.19M | -5.14M | -756.47K | -706.59K | -123.87K | -285.88K | -535.14K | -467.43K | -89.96K | -6.37K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -1.51M | 8.61M | -2.88M | -3.3M | -11.46M | 919.39K | 629.89K | 574.41K | -80.58K | -527.53K | -329.38K | -87.3K | -6.37K |
Net Income | -1.51M | 9.39M | -2.88M | -3.3M | -11.51M | 576.07K | 238.69K | 840.82K | -346.99K | -527.53K | -191.33K | -84.65K | -6.37K |
Selling & General & Admin | 1.56M | 5.49M | 1.09M | 1.08M | 4.49M | 756.47K | 706.59K | 123.87K | 285.88K | 535.14K | 467.43K | 89.96K | n/a |
Research & Development | 196.91K | 1.58M | 331.81K | 104.07K | 1.67M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | 13.14K | 23.24K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.37K |
Operating Expenses | 1.75M | 7.07M | 1.43M | 1.2M | 6.17M | 756.47K | 706.59K | 123.87K | 285.88K | 535.14K | 467.43K | 89.96K | -6.37K |
Interest Expense | n/a | -23.82K | -7.12K | -3.26K | -65.63K | n/a | n/a | n/a | n/a | n/a | -138.05K | -2.65K | n/a |
Selling & Marketing Expenses | 280.55K | -3.07M | 120.06K | 11.04K | 3.07M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.99M | 8.61M | 1.44M | 1.2M | 7.71M | 756.47K | 706.59K | 123.87K | 285.88K | 535.14K | 467.43K | 89.96K | -6.37K |
Income Tax Expense | n/a | -783.9K | n/a | n/a | 49.38K | 343.33K | 391.2K | -266.41K | 266.41K | n/a | -138.05K | -2.65K | n/a |
Shares Outstanding (Basic) | 20.91M | 20.91M | 20.91M | 20.74M | 18.63M | 15.44M | 15.44M | 15.44M | 15.44M | n/a | n/a | n/a | 15.44M |
Shares Outstanding (Diluted) | 20.91M | 20.91M | 20.91M | 20.74M | 18.63M | 15.44M | 15.44M | 3.86M | 3.86M | n/a | n/a | n/a | n/a |
EPS (Basic) | -0.07 | 0.53 | -0.14 | -0.16 | -0.62 | 0.08 | 0.01 | 0.04 | -0.02 | n/a | -0.05 | n/a | -0.00 |
EPS (Diluted) | -0.07 | 0.28 | -0.14 | -0.16 | -0.62 | 0.33 | 0.01 | 0.04 | -0.09 | n/a | -0.05 | n/a | n/a |
EBITDA | -1.48M | 11.8M | -1.4M | -1.17M | -11.1M | -2.43M | -2.04M | -822.16K | -491.17K | -542.75K | -329.38K | -92.61K | -6.37K |
EBIT | -1.51M | 11.53M | -1.42M | -1.19M | -11.53M | -756.47K | -706.59K | -656.68K | -285.88K | -535.14K | -467.43K | -89.96K | n/a |
Depreciation & Amortization | 23.95K | 3.22M | 17.98K | 23.53K | 429.48K | -1.68M | -1.34M | -698.28K | -205.3K | -7.61K | 138.05K | -2.65K | 55.81K |